| 纯度 | >95%SDS-PAGE. |
| 种属 | Human |
| 靶点 | FKBP6 |
| Uniprot No | O75344 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-327aa |
| 氨基酸序列 | MGGSALNQGV LEGDDAPGQS LYERLSQRML DISGDRGVLK DVIREGAGDL VAPDASVLVK YSGYLEHMDR PFDSNYFRKT PRLMKLGEDI TLWGMELGLL SMRRGELARF LFKPNYAYGT LGCPPLIPPN TTVLFEIELL DFLDCAESDK FCALSAEQQD QFPLQKVLKV AATEREFGNY LFRQNRFYDA KVRYKRALLL LRRRSAPPEE QHLVEAAKLP VLLNLSFTYL KLDRPTIALC YGEQALIIDQ KNAKALFRCG QACLLLTEYQ KARDFLVRAQ KEQPFNHDIN NELKKLASCY RDYVDKEKEM WHRMFAPCGD GSTAGES |
| 预测分子量 | 39 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于FKBP6重组蛋白的3篇代表性文献的简要总结：
1. **文献名称**：*FKBP6. a novel immunophilin, regulates protein translation and stress response*
**作者**：Smith A, et al.
**摘要**：研究利用大肠杆菌系统成功表达并纯化FKBP6重组蛋白，发现其通过结合核糖体调控蛋白质翻译效率，并参与细胞氧化应激反应。
2. **文献名称**：*Structural and functional characterization of recombinant human FKBP6*
**作者**：Chen L, et al.
**摘要**：通过X射线晶体学解析了FKBP6重组蛋白的三维结构，揭示其独特的PPIase活性结构域，并证明其与钙离子通道蛋白的互作可能影响生殖细胞发育。
3. **文献名称**：*FKBP6 deficiency disrupts homologous recombination in mammalian meiosis*
**作者**：Yamamoto K, et al.
**摘要**：利用重组FKBP6蛋白进行体外实验，发现其通过调控减数分裂中同源重组修复过程维持基因组稳定性，突变体导致小鼠模型生殖缺陷。
注：以上文献信息为基于领域知识的模拟概括，实际文献需通过PubMed或Web of Science检索获取。若研究较少，可扩展检索FKBP家族(如FKBP5/12)或重组蛋白表达技术相关文献作为参考。
**Background of FKBP6 Recombinant Protein**
FKBP6 (FK506-binding protein 6) is a member of the FKBP family, a group of proteins characterized by their conserved FK506-binding domain. These proteins often exhibit peptidyl-prolyl isomerase (PPIase) activity, enabling them to modulate protein folding, trafficking, and interactions by catalyzing cis-trans isomerization of proline residues. FKBP6. specifically, is notable for its roles in reproductive biology, cancer, and neurological processes. It is encoded by the *FKBP6* gene, located on human chromosome 7. and has been implicated in gametogenesis, particularly in meiosis regulation, as its deficiency is linked to male infertility in animal models.
Recombinant FKBP6 is produced using biotechnological methods, typically by expressing the *FKBP6* gene in bacterial (e.g., *E. coli*) or eukaryotic systems (e.g., mammalian cells) to ensure proper folding and post-translational modifications. The purified protein retains functional domains, including the FKBP domain, which facilitates interactions with partner proteins like calmodulin or components of the mTOR signaling pathway.
Research on FKBP6 recombinant protein has expanded due to its potential involvement in disease mechanisms. For instance, it interacts with the aryl hydrocarbon receptor (AhR), influencing cellular stress responses. In cancer, FKBP6 may act as a tumor suppressor, with downregulation observed in gliomas and leukemias. Additionally, its role in protein quality control pathways highlights relevance in neurodegenerative disorders.
The availability of recombinant FKBP6 enables structural studies, drug discovery (e.g., targeting PPIase activity), and functional assays to dissect its biological roles. Its application spans molecular biology, pharmacology, and clinical research, underscoring its importance in understanding cellular regulation and disease pathology.
×
